These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 905583)

  • 41. Synthesis of stable thromboxane A2 analogs: pinane thromboxane A2 (PTA2) and carbocyclic thromboxane A2 (CTA2).
    Nicolaou KC; Magolda RL
    Methods Enzymol; 1982; 86():400-9. PubMed ID: 7132765
    [No Abstract]   [Full Text] [Related]  

  • 42. Bioassay of thromboxane A2 by contraction of guinea-pig lung parenchymal strip.
    Spławiński J; Wojtaszek B; Marcinkiewicz E
    Thromb Res; 1981 Jan 1-15; 21(1-2):35-44. PubMed ID: 6112804
    [No Abstract]   [Full Text] [Related]  

  • 43. Fenalcomine hydrochloride inhibits the action of PG on the smooth muscle but stimulates that of TXA2.
    Pham Huu Chanh ; Pham Huu Chanh A; van Thoai MN; Sokan I
    Adv Prostaglandin Thromboxane Res; 1980; 6():411-5. PubMed ID: 7386277
    [No Abstract]   [Full Text] [Related]  

  • 44. Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery.
    Salzman PM; Salmon JA; Moncada S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):240-7. PubMed ID: 7005425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of prostacyclin and thromboxane A2 in the cardiovascular system].
    Ismailov ShI; Val'dman AV
    Kardiologiia; 1981 Mar; 21(3):111-6. PubMed ID: 7014974
    [No Abstract]   [Full Text] [Related]  

  • 46. Production of thromboxane A2 by the kidney in glycerol-induced acute renal failure in the rabbit.
    Benabe JE; Klahr S; Hoffman MK; Morrison AR
    Prostaglandins; 1980 Mar; 19(3):333-47. PubMed ID: 7384543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Thromboxane A2 antagonist, prostacyclin (PGI2)--its in vivo secretion and action mechanism].
    Okuma M
    Nihon Rinsho; 1978 Dec; 36(12):3830-5. PubMed ID: 372621
    [No Abstract]   [Full Text] [Related]  

  • 48. The biochemical pharmacology of thromboxane synthase inhibition in man.
    FitzGerald GA; Reilly IA; Pedersen AK
    Circulation; 1985 Dec; 72(6):1194-201. PubMed ID: 3905048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transformations of prostaglandin H2 in the cat brain.
    Bishai I; Coceani F
    Biochim Biophys Acta; 1981 Apr; 664(1):1-9. PubMed ID: 6894549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
    Patscheke H; Stegmeier K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
    [No Abstract]   [Full Text] [Related]  

  • 51. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP; Watts IS
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
    Johnson GJ; Dunlop PC; Leis LA; From AH
    Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.
    Ashton JH; Ogletree ML; Michel IM; Golino P; McNatt JM; Taylor AL; Raheja S; Schmitz J; Buja LM; Campbell WB
    Circulation; 1987 Oct; 76(4):952-9. PubMed ID: 3652429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of specific inhibitors of thromboxane A2 formation.
    Ladd N; Lewis GP
    Br J Pharmacol; 1980 May; 69(1):3-5. PubMed ID: 7378655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.
    Samuelsson B
    Acta Biol Med Ger; 1976; 35(8-9):1055-63. PubMed ID: 1007751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of thromboxanes and prostaglandin endoperoxides in the pathogenesis of eicosanoid induced sudden death.
    Lefer AM; Burke SE; Smith JB
    Thromb Res; 1983 Nov; 32(3):311-20. PubMed ID: 6419378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 59. Metabolism of arachidonic acid and its endoperoxide prostaglandin H2 in isolated lungs from guinea-pigs and rabbits [proceedings].
    Alabaster VA
    J Physiol; 1979 Aug; 293():28P. PubMed ID: 387945
    [No Abstract]   [Full Text] [Related]  

  • 60. Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2.
    Nishizawa EE; Williams DJ; Connell CL
    Thromb Res; 1983 May; 30(3):289-96. PubMed ID: 6868025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.